Estrella Immunopharma Accounts Payable

Estrella Immunopharma (ESLA) currently reports a accounts payable of $15K as of March 2026. That compares with $14K in the prior-year period — up 6.9% year over year. Use the charts on this page to explore Estrella Immunopharma's accounts payable history and peer comparisons.

Estrella Immunopharma's accounts payable increased from $14K to $15K — a 6.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Estrella Immunopharma reported $15K in accounts payable as of March 2026. That compares with $14K in the prior-year period — up 6.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $15K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Estrella Immunopharma, and consider following ESLA for alerts when major investors trade the stock.